the hanover insurance group inc. - THG

THG

Close Chg Chg %
162.79 0.95 0.58%

Closed Market

163.74

+0.95 (0.58%)

Volume: 209.04K

Last Updated:

Nov 22, 2024, 3:59 PM EDT

Company Overview: the hanover insurance group inc. - THG

THG Key Data

Open

$162.02

Day Range

162.01 - 164.90

52 Week Range

119.36 - 165.28

Market Cap

$5.86B

Shares Outstanding

36.03M

Public Float

35.71M

Beta

0.70

Rev. Per Employee

N/A

P/E Ratio

16.15

EPS

$10.20

Yield

208.92%

Dividend

$0.85

EX-DIVIDEND DATE

Sep 13, 2024

SHORT INTEREST

N/A

AVERAGE VOLUME

181.82K

 

THG Performance

1 Week
 
0.07%
 
1 Month
 
10.68%
 
3 Months
 
19.16%
 
1 Year
 
34.48%
 
5 Years
 
22.45%
 

THG Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 7
Full Ratings ➔
An error occurred while fetching the data.

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 169.833
Number of Ratings 7 Current Quarters Estimate 3.366
FY Report Date 12 / 2024 Current Year's Estimate 11.396
Last Quarter’s Earnings 3.05 Median PE on CY Estimate N/A
Year Ago Earnings 1.56 Next Fiscal Year Estimate 13.70
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 7 5 7 7
Mean Estimate 3.37 3.61 11.40 13.70
High Estimates 3.54 3.89 11.55 14.17
Low Estimate 3.19 3.38 11.25 13.25
Coefficient of Variance 4.53 5.68 1.12 2.48

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 4 5 5
OVERWEIGHT 0 0 1
HOLD 3 3 3
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Overweight Overweight Overweight

Insider Actions for The Hanover Insurance Group Inc. - THG

Date Name Shares Transaction Value
Oct 4, 2024 Jeffrey Mark Farber Executive Vice President 85,741 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $150.02 per share 12,862,864.82
May 29, 2024 Jane D. Carlin Director N/A Open market or private sale of non-derivative or derivative security Non-derivative transaction at $132.25 per share 0.00
May 17, 2024 Theodore H. Bunting Director 5,211 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 17, 2024 Joseph R. Ramrath Director 32,010 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 17, 2024 Cynthia L. Egan Director 12,759 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 17, 2024 Kathleen S. Lane Director 5,778 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 17, 2024 Elizabeth A. Ward Director 4,059 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 17, 2024 James Paul Condrin Director 4,532 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 17, 2024 Francisco Alberto Aristeguieta Silva Director 3,233 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 17, 2024 Kevin J. Bradicich Director 8,272 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 9, 2024 Willard T. Lee Executive Vice President 4,398 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $135.94 per share 597,864.12
Apr 2, 2024 Bryan J. Salvatore Executive Vice President 23,516 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Apr 2, 2024 Denise Tinger M. Lowsley Executive Vice President 5,689 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Apr 2, 2024 Warren Ellison Barnes SVP & Princpl. Accntg. Officer 3,499 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Apr 2, 2024 Richard William Lavey Executive Vice President 36,243 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Apr 2, 2024 Dennis F. Kerrigan Executive Vice President 8,442 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Apr 2, 2024 John Conner Roche President and CEO; Director 113,599 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Apr 2, 2024 David J. Lovely Executive Vice President 1,443 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 29, 2024 Jeffrey Mark Farber Executive Vice President 15,332 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 29, 2024 Richard William Lavey Executive Vice President 35,599 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00

The Hanover Insurance Group Inc. in the News